ARCHIVES

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

This article is from The Cancer Letter archive.

Vol. 17 No. 45 | November 22, 1991

Download PDF Visit The Full Archive

Related Articles

NCI to Fund 122 More Grants in FY04

March 28, 2003

NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship.

April 20, 2001

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

May 3, 2002

Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases

October 21, 2011

Antidepressant Provides Cool Choice For Hot Flashes

February 22, 2002

MSKCC Selects Hartford HealthCare As First Member in Cancer Alliance

September 27, 2013